In contrast to the mechanism by which PGC-1α upregulates OXPHOS, this study indicated that PGC-1α enhances global energy metabolism flexibility of breast cancer cells, thereby producing resistance to bioenergy interference drugs such as metformin [80]. Here, PPARGC1A is linked to breast cancer.